Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.22

+2.1%

Nov 24 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (973)	4/18/2000 6:58:00 AM
From: scott_jiminez	Read Replies (1) of 52153

Vector - IBPI and the entire biotech IPO market has crashed and burned of late (http://finance.yahoo.com/q?s=ADLR+ALTH+CALP+DASI+DVSA+EXEL+IBPI+LEXG%0DMAXY+RIGL+SGMO+SQNM+TLRK+TNOX+&d=1y). On 3 March, Diversa closed at $149. 17 April, DVSA = $17. The 89% loss qualifies the stock as a charter member of my Biotech devaluation fund. Within this group, ALDR and DASI postponed their offerings and RIGL joined Louis and Ella in the chorus, 'Let's just call the whole thing off'. Any opinion regarding which bargain(s) may be greater than others?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next